Concepedia

Concept

pharmacology

Parents

Children

1.6M

Publications

78.2M

Citations

2.6M

Authors

44.6K

Institutions

Heterocycle-Driven Pharmacology

1883 - 1893

During the 1883-1893 period, research concentrated on method development for sulfur- and nitrogen-rich heterocycles, with thionylamines, tetrazoles, isoxazoles, and pyrrolidines emerging as core scaffolds aligned with pharmacological goals. Reaction-driven ring formation from nitro compounds, alkalis, and hydrazine enabled rapid diversification of heterocycles from common substrates, illustrating an early medicinal chemistry paradigm of building diversity from shared substrates. Bioactivity-focused analysis of natural products and drug-like molecules—spanning narcotin, bromäthylamins, phenmiazinderivate, and thiobenzamide products—emphasized phytochemical pharmacology and nascent structure-activity considerations. Constitutional and structural chemistry framing pharmacology through investigations of chemical constitution and molecular structure contributed to early ideas about structure-activity relationships.

Synthesis of sulfur- and nitrogen-rich heterocycles forms a core methodological pattern; thionylamines, tetrazoles, isoxazoles, pyrrolidines and related scaffolds are developed and aligned with pharmacological goals, illustrating early medicinal chemistry method development [10], [11], [12], [14], [15], [16].

Reaction-driven heterocycle formation through nitro compounds, alkalis, and hydrazine enabling isoxazole and related ring formation; demonstrates a methodological paradigm of deriving diverse heterocycles from common substrates [10], [12], [13], [18].

Bioactivity-focused natural product and drug-like molecules analysis spanning narcotin, bromäthylamins, phenmiazinderivate, thiobenzamide products, emphasizing phytochemical analyses and pharmacology [2], [4], [9], [19], [20].

Constitutional/structural chemistry framing pharmacology through examination of chemical constitution and molecular structure: natriumacetessigäthers, β-Methyl-Pyridylketon, diazoderivat des Methyluracils; shaping understanding of structure-activity relationships [5], [16], [17].

Mechanism-Based Pharmacology

1894 - 1923

Therapeutics-Driven Pharmacodynamics

1924 - 1947

Autonomic-Endocrine Pharmacology

1948 - 1954

Enzymatic Catecholamine Metabolism

1955 - 1961

Metabolism-Driven Neuropharmacology

1962 - 1968

Cytochrome-Driven Pharmacology

1969 - 1975

Endothelium-Driven Signaling Pharmacology

1976 - 1991

Receptor Signaling Network Pharmacology

1992 - 1998

ADME-Driven Translational Pharmacology

1999 - 2017

Multi-Modal Immuno-Oncology

2018 - 2024